Live Breaking News & Updates on Rocket Pharmaceuticals
Stay updated with breaking news from Rocket pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Avoro Capital Advisors LLC increased its stake in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 0.9% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,260,900 shares of the biotechnology company’s stock after buying an additional 10,900 shares during the quarter. […] ....
Calliditas Therapeutics AB (publ) (NASDAQ:CALT – Get Free Report) and Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, dividends, risk, profitability, analyst recommendations and institutional ownership. Earnings & Valuation This table compares […] ....
Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report) and Calliditas Therapeutics AB (publ) (NASDAQ:CALT – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, dividends, analyst recommendations and valuation. Profitability This table compares Rocket Pharmaceuticals […] ....
Rocket Pharmaceuticals, Inc. , a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced that the European Commission (EC), based on a positive. ....
Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) have received a consensus rating of “Moderate Buy” from the nine ratings firms that are currently covering the firm, MarketBeat reports. One analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 12-month price […] ....